Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Ascorbic Acid Attenuates Senescence of Human Osteoarthritic Osteoblasts.

Burger MG, Steinitz A, Geurts J, Pippenger BE, Schaefer DJ, Martin I, Barbero A, Pelttari K.

Int J Mol Sci. 2017 Nov 24;18(12). pii: E2517. doi: 10.3390/ijms18122517.

2.

Nasal chondrocytes as a neural crest-derived cell source for regenerative medicine.

Pelttari K, Mumme M, Barbero A, Martin I.

Curr Opin Biotechnol. 2017 Oct;47:1-6. doi: 10.1016/j.copbio.2017.05.007. Epub 2017 May 25. Review.

PMID:
28551498
3.

Regenerative Potential of Tissue-Engineered Nasal Chondrocytes in Goat Articular Cartilage Defects.

Mumme M, Steinitz A, Nuss KM, Klein K, Feliciano S, Kronen P, Jakob M, von Rechenberg B, Martin I, Barbero A, Pelttari K.

Tissue Eng Part A. 2016 Nov;22(21-22):1286-1295. Epub 2016 Oct 11.

PMID:
27633049
4.

A potential role of homeobox transcription factors in osteoarthritis.

Pelttari K, Barbero A, Martin I.

Ann Transl Med. 2015 Oct;3(17):254. doi: 10.3978/j.issn.2305-5839.2015.09.44.

5.

Bone-forming capacity of adult human nasal chondrocytes.

Pippenger BE, Ventura M, Pelttari K, Feliciano S, Jaquiery C, Scherberich A, Walboomers XF, Barbero A, Martin I.

J Cell Mol Med. 2015 Jun;19(6):1390-9. doi: 10.1111/jcmm.12526. Epub 2015 Feb 16.

6.

Adult human neural crest-derived cells for articular cartilage repair.

Pelttari K, Pippenger B, Mumme M, Feliciano S, Scotti C, Mainil-Varlet P, Procino A, von Rechenberg B, Schwamborn T, Jakob M, Cillo C, Barbero A, Martin I.

Sci Transl Med. 2014 Aug 27;6(251):251ra119. doi: 10.1126/scitranslmed.3009688.

7.

Do we really need cartilage tissue engineering?

Pelttari K, Wixmerten A, Martin I.

Swiss Med Wkly. 2009 Oct 17;139(41-42):602-9. doi: smw-12742. Review.

PMID:
19918699
8.

In vitro and in vivo validation of human and goat chondrocyte labeling by green fluorescent protein lentivirus transduction.

Miot S, Gianni-Barrera R, Pelttari K, Acharya C, Mainil-Varlet P, Juelke H, Jaquiery C, Candrian C, Barbero A, Martin I.

Tissue Eng Part C Methods. 2010 Feb;16(1):11-21. doi: 10.1089/ten.TEC.2008.0698.

PMID:
19327004
9.

Calcification or dedifferentiation: requirement to lock mesenchymal stem cells in a desired differentiation stage.

Dickhut A, Pelttari K, Janicki P, Wagner W, Eckstein V, Egermann M, Richter W.

J Cell Physiol. 2009 Apr;219(1):219-26. doi: 10.1002/jcp.21673.

PMID:
19107842
10.

The use of mesenchymal stem cells for chondrogenesis.

Pelttari K, Steck E, Richter W.

Injury. 2008 Apr;39 Suppl 1:S58-65. doi: 10.1016/j.injury.2008.01.038. Review.

PMID:
18313473
11.

Secretion of matrix metalloproteinase 3 by expanded articular chondrocytes as a predictor of ectopic cartilage formation capacity in vivo.

Pelttari K, Lorenz H, Boeuf S, Templin MF, Bischel O, Goetzke K, Hsu HY, Steck E, Richter W.

Arthritis Rheum. 2008 Feb;58(2):467-74. doi: 10.1002/art.23302.

12.

Subtractive gene expression profiling of articular cartilage and mesenchymal stem cells: serpins as cartilage-relevant differentiation markers.

Boeuf S, Steck E, Pelttari K, Hennig T, Buneb A, Benz K, Witte D, Sültmann H, Poustka A, Richter W.

Osteoarthritis Cartilage. 2008 Jan;16(1):48-60. Epub 2007 Jul 2.

13.

Differentiation potential and ectopic cartilage formation capacity of human mesenchymal stem cells derived from bone marrow, adipose tissue and synovium.

Dickhut A, Pelttari K, Bischel O, Richter W.

J Stem Cells Regen Med. 2007 May 16;2(1):20-1. eCollection 2007. No abstract available.

PMID:
24692883
14.

Chondrocyte secreted CRTAC1: a glycosylated extracellular matrix molecule of human articular cartilage.

Steck E, Bräun J, Pelttari K, Kadel S, Kalbacher H, Richter W.

Matrix Biol. 2007 Jan;26(1):30-41. Epub 2006 Sep 16.

PMID:
17074475
15.

Supplemental Content

Loading ...
Support Center